United States · FDA National Drug Code directory
Valsartan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-047_d9c3b1ac-bbb0-4974-b337-88e247093c72
- Product NDC
- 62332-047
- Form
- TABLET
- Composition / generic term
- Valsartan
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160520
- Source listing expiry
- 20261231
Source-listed ingredients
- VALSARTAN — 320 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (62332-047-30) · 62332-047-30
- 500 TABLET in 1 BOTTLE (62332-047-71) · 62332-047-71
- 90 TABLET in 1 BOTTLE (62332-047-90) · 62332-047-90
- 1000 TABLET in 1 BOTTLE (62332-047-91) · 62332-047-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →